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Introduction
AS is an inflammatory rheumatic disease mainly involving
the axial skeleton. Forty percent of AS patients develop
periphery mono-/oligoarthritis [1].
The SM of inflamed peripheral joints in AS (Fig. 1) in
certain cases resembles RA with intense mononuclear cell
infiltration forming foci similar to germinal centers (GC)
that contain B and T lymphocytes as well as plasma cells
Abstract
The synovial membrane (SM) of affected joints in ankylosing spondylitis (AS) is infiltrated by germinal
center-like aggregates (foci) of lymphocytes similar to rheumatoid arthritis (RA). We characterized the
rearranged heavy chain variable segment (VH) genes in the SM for gene usage and the mutational pattern
to elucidate the B lymphocyte involvement in AS.
Cryosections from an AS-derived SM were stained for B and T lymphocytes. B cells were isolated from
different areas of a focus. The rearranged VH genes were amplified by semi-nested polymerase chain
reaction (PCR) using oligonucleotides specific for the six different VH families and heavy chain joining
segments (JHs). PCR products were cloned and sequenced.
Fifty-nine of 70 different heavy chain gene rearrangements were potentially functional. Most of the
rearranged genes were mutated (range, 1–15%). Thirty of 70 products had a mutational pattern typical
for antigen selection. Most of the rearranged VH genes belonged to the VH3 family (54%), consistent
with data from healthy donors and patients with RA, while VH4 genes, in contrast to RA, were
identified less frequently (10%) and VH5 genes were over-represented (11%). In contrast to RA,
neither VH6 genes nor the autoimmunity-prone VH4-34 were seen, whereas another autoimmunity-
prone gene, V3-23, was predominantly used (11%). One VH1-derived and one VH3-derived B cell
clone were expanded. CDR3 were shorter and more variable in length than in RA.
Comparable with RA and reactive arthritis, there is a biased repertoire of selected VH genes, whereas
the panel of represented genes is different and less clonal expansion was observed.
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[2,3]. Recent immunohistologic analysis of five AS SMs
demonstrated B cell rich infiltrates in two cases, whereas
no B cells were detected in the three others [4].
The VH germline repertoire consists of 123 (44 functional)
VH segments subdivided into seven VH families (see sup-
plementary material). Antibodies are encoded by one VH
segment rearranged to one or several of 25 heavy chain
diversity segments (DHs) and one of six JHs [5]. The locus
of rearrangement, individual for each B lymphocyte clone,
is the CDR3 [6]. Only rearrangements with translatable
nucleotide triplets lead to antibody formation, others are
nonfunctional. There is a biased use of particular germline
VH genes in the VH repertoire. An over-representation of
VH4 genes in the autoimmune repertoire has been
described [7,8]. A negative selection of VH4 takes place
in the peripheral blood lymphocytes from healthy individu-
als as a means of avoiding autoimmunity [9].
An antigen-driven immune response, characterized by a
ratio of mutations leading to amino acid replacement to
silent mutations (R:S ratio) >3 [10] within the comple-
mentarity determining region (CDR), takes place within the
GC of lymphatic organs. Similar clonal development of
antibody VH genes has been demonstrated in the SM in
RA patients [11–15] and in reactive arthritis (ReA)
patients [16]. The B cell subset in AS joints has not yet
been characterized. We analyzed the repertoire and distri-
bution of rearranged VH genes to elucidate B lymphocyte
involvement in AS, and to investigate similarities to and dif-
ferences from RA.
Materials and methods
Tissue preparation and staining
A SM of the right hip was obtained from a 57-year-old man,
who had suffered from AS for 30 years, requiring total endo-
prothetic joint replacement. Frozen sections (8 mm) of the
immediately snap-frozen tissue sample were screened for B
and T cells by double immunohistological staining with anti-
CD20 and anti-CD3 monoclonal antibodies using the alka-
line phosphatase–anti-alkaline phosphatase and streptavidin
biotin horseradish peroxidase technique [17,18]. The stained
B lymphocytes from serial sections taken at 50 mm intervals
were isolated by microdissection, and DNA preparation fol-
lowed (see supplementary material).
VH PCR
DNA was subjected to a semi-nested PCR for VH genes
(see supplementary material). Thirty-five cycles of PCR,
using a mix of six oligonucleotides specific for the different
VH families as primers at the 5¢ end and a mix of oligonu-
cleotides corresponding to the known JH overlapping to a
part of the intron sequence as primers at the 3¢ end, were
followed by 35 cycles with 1 ml of the first PCR products
and individual VH and JH primers (at a more 5¢ position)
(Table 1). A similar PCR without DNA was run as a nega-
tive control.
Template generation and sequence analysis
PCR products of the expected 350 base pair (bp) length
were detected by standard agarose gel electrophoresis
and purified. The purified DNA template was bacterially
subcloned followed by plasmid isolation and sequencing.
Sequences were analyzed by homology comparison with
the EMBL and GenBank gene databases (see supplemen-
tary material).
Results
Immunohistological analysis of the inflamed SM revealed
foci rich in B and T lymphocytes in a formation similar to
GC (Fig. 1) [2]. The B lymphocytes of one focus were iso-
lated from four not directly consecutive sections about
50 mm apart (2c, 3a, 3b, 5c). An estimated number of 150
B lymphocytes could be isolated from each section.
The VH gene usage
Except for the negative control, all VH PCRs led to a product
of the expected length (350 bp). All sequences reported in
the present paper are accessible on the EMBL database.
Seventy individually rearranged VH genes were character-
ized by sequence analysis (Table 2): 14 (20%) belonged
to the VH1 family, 3 (4%) to VH2, 38 (54%) to VH3, 7
(10%) to VH4, and 8 (11%) belonged to the VH5 family.
No sequences corresponded to VH6 (Fig. 2).
Twelve genes in all were nonfunctionally rearranged, with
the highest proportion in VH3 (18%), about 14% in VH1,
VH4 and VH5, and none in VH2.
Figure 1
The synovial focus. Double-immunohistological staining (anti-CD20
alkaline phosphatase–anti-alkaline phosphatase and anti-CD3
streptavidin biotin horseradish peroxidase reaction) of 8 mm sections
from frozen SM obtained by total joint replacement of an AS patient’s
right hip. B cells, red staining; T cells, brown staining.VH1 genes
Fourteen individual rearrangements represented VH1
genes. The most often represented VH1 gene was DP75
(four products) followed by DP10, DP14, DP21 and DP25
(two products each). Out of 14 distinct VH1–DH–JH
sequences, 2 were nonfunctional (14%). CDR3 lengths
varied between 18 and 39 bp (mean, 28.5 bp).
Four of the VH1 products (F5-2c4, F5-3a4, F5-3b4 and
5c-4m6) deriving from different slides had an identically
rearranged CDR3 and consecutively represent members
of an expanding B lymphocyte clone (Fig. 3a). With 99%
homology to DP21, they shared three mutations within the
framework region (FR).
Five productively rearranged genes were highly mutated with
a range of 12 (F5-3a3) to 29 mutations to their respective
germline (gl) gene. The R:S ratio for the CDR was >3 and
lower for the FR, indicating antigen-driven mutation [10].
VH2 genes
Three different VH2 rearrangements were determined. All
were potentially functional and > 95% homologous to the
respective gl gene. The number of mutations ranged from 2
(5c-VH22s) to 10 (5c-VH26s). R:S ratios were quite low,
with a maximum of 2.0 in the CDR (5c-VH26s). CDR3
lengths varied between 15 and 45 bp (mean, 32 bp).
VH3 genes
Thirty-eight different VH3 rearrangements were character-
ized: eight were most homologous to DP47/V3-23 (21%),
five to DP50 (13%), four each to DP54 and DP31 (11%),
respectively, and three each to DP49, DP35, DP51 and
DP77 (8%), respectively. Seven (18.4%) VH3 genes were
nonfunctionally rearranged. CDR3 lengths varied from 6 to
35 bp (mean, 27.2 bp).
One case of clonal expansion within the VH3 genes was
observed, represented by the VH3–JH4 rearrangements
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Table 1
The oligonucleotide sequences of primers
Oligonucleotides (2.5 mM)
JH1   5’ CGTCGTCGAC CAGGGTGCCC TGGCCCCAGT GC    (101–109)
JH2   5’ CGTCGTCGAC CAGGGTGCCC TGGCCCCAGT GC    (101–109)
JH3   5’ CGTCGTCGAC ATTGTCCCTT GGCCCCAGAC ATCA  (100–108)
JH4   5’ CGTCGTCAAC CACGGTTCCT TGGCCCCAGT AG    (101–109)
JH5   5’ CGTCGTCGAC GTGACCAGGG TTCCTTGGCC CCAGG (102–110)
JH6   5’ CGTCGTCGAC GTGGTCCCTT GCCCCCAGAC GTCC  (100–108)
VH1   5’ CTACGTCGAC CCTCAGTGAA GGTYTCCTGC AAGGC (16–24)
VH2   5’ GCACGTCGAC GTCCTGCGCT GGTGAAASCC ACACA (16–24)
VH3   5’ GTACGTCGAC GGGGTCCCTG AGCTCTCCTG TGCAG (15–24)
VH4   5’ CGTCGTCGAC CCTGTCCCTC ACCTGCRCTG TC    (16–24)
VH5   5’ CGACGTCGAC AAAAAGCCCG GGGAGTCTCT GARGA (12–20)
VH6   5’ CGTCGTCGAC CTGTGCCATC TCCGGGGACA GTG   (21–29)
JH Intron 1,2-4,5 5’GACTCACCTG AGGAGACGGT GACC
JH Intron 3,6     5’TCTTGCCTGA GGAGACGGTG ACCRT
All oligonucleotides contain a 5¢ SalI restriction site (G/TCGAC). The corresponding amino acid positions are presented in parentheses. The VH1
oligonucleotide also perfectly matches VH7.
Figure 2
Distribution of the VH families among the PCR products obtained from
different slides (2c, 3a, 3b and 5c). Bars for each section represent
the respective number of products for each indicated VH family.Arthritis Research    Vol 3 No 3 Voswinkel et al
Table 2
The rearranged heavy chain variable segment (VH) genes, their functionality, respective germline gene (homology), ratio of
mutations leading to amino acid replacement to silent mutations (R:S ratio) with the number of mutations for the complementarity
determining region (CDR) and the framework region (FR), heavy chain joining segments (JH) and CDR3 lengths
VH Gene Functionality Germline  Homology (%) R:S ratio CDR R:S ratio FR JH CDR3 (base pairs)
1 F5-3b6 nf DP6 97 0 2/0 6 26
F5-3a3 pf DP7 91 4/0 4/4 3 24
F5-2c2 pf DP14 100 0 0 2 30
F5-2c6 pf DP14 99 0 0 6 30
2c-3m4b pf DP25 89 5/6 3/10 3 39
F5-5c6 pf DP25 92 9/1 4/2 6 39
F5-2c4* pf DP21 99 0 2/1 1 or 2 or 4 21
3a-5m3 pf DP21 100 0 1/0 5 18
F5-3a6 pf DP10 98 2/0 1/0 6 36
5c-4m4 pf DP10 88 9/2 11/7 4 or 5 18
F5-3a2 pf DP75 97 2/1 3/1 1 27
F5-5c1 pf DP75 98 0/0 2/0 1 30
F5-5c2 nf DP75 96 1/2 2/0 Undetermined 23
5c-4m7 pf DP75 93 6/2 4/4 4 30
2 2c-VH24s pf HUMIGVH2e 97 1/1 2/0 4 45
5c-VH22s pf HUMIGVH2e 99 1/1 0/0 2 36
5c-VH26s pf HUMIGVH2f 95 2/1 2/5 6 15
3 2c-17m14 pf DP54 95.5 3/2 4/2 2 or 5 30
2c-19m8 pf DP54 95.5 4/1 3/2 4 12
3a-19m6 pf DP54 95.5 3/0 5/2 4 12
3b-18m4 nf DP54 100 0/0 0/1 3 23
5c-21m1 nf DP54 96.7 5/0 1/0 5 or 6 22
2c-18m7 pf DP47/V3-23 92.4 8/2 2/4 3 30
2c-21m2 pf DP47/V3-23 96.9 3/0 2/2 6 33
2c-21m3 pf DP47/V3-23 90.1 7/6 3/3 6 45
3a-19m8 pf DP47/V3-23 93.3 3/2 6/4 4 24
F5-3a21 pf DP47/V3-23 92.9 2/0 4/2 5 or 6 45
5c-19m9 pf DP47/V3-23 95.5 3/3 4/0 4 33
5c-21m5 pf DP47/V3-23 88.4 10/1 8/6 6 27
F5-5c18 pf DP47/V3-23 91.2 6/1 3/3 3 24
3b-17m1 pf DP46 96.9 2/1 2/1 2 42
F5-3b21 pf DP46 95.9 0/1 1/1 6 21
2c-20m10 nf DP50 85.7 5/2 10/0 5 26
3a-16m4 pf DP50 95.8 4/1 0/3 1 36
3b-17m6 pf DP50 93.3 7/2 4/2 2 or 4 36
5c-19m7 nf DP50 87.8 7/2 5/1 4 31
5c-20m8 pf DP50 91.1 9/3 5/3 5 24
2c-17m9 pf DP49 88.8 3/4 8/10 2 6
2c-20m9 pf DP49 93.8 5/1 6/2 5 24
5c-19m4 nf DP49 94.0 5/3 5/0 4 30
2c-20m8 pf DP51 98.2 0/0 3/1 5 27
3b-16m4 pf DP51 93.3 6/2 4/3 1 27
5c-20m6 nf DP51 90.2 13/2 1/6 5 29
2c-19m2 pf DP31 97.8 2/2 1/0 4 18
F5-3a17 pf DP31 88 5/2 2/1 2 36
3a-18m2 pf DP31 93.6 4/0 2/1 3 12
3a-19m2 pf DP31 97.3 2/1 0/1 4 30
2c-18m3 pf DP35 100 0/0 0/0 3 24
2c-19m7 pf DP35 94.6 4/2 4/2 4 33
5c-21m8 nf DP35 94.6 3/1 0/5 6 31
3a-20m7 pf DP77 88.3 12/2 9/4 5 33
F5-5c16 pf DP77 94.3 4/0 6/2 1 27
2c-21m6 nf DP52 98.2 0/0 2/0 6 25
3a-18m5 pf DP29 89.9 6/1 9/2 3 39
5c-21m2 pf DP53 97.3 3/0 2/1 6 12
Continued opposite3a-19m6 and 2c-19m8 (Fig. 3b). These genes, with 95.5%
homology to DP54, shared four replacement mutations,
and six mutations each were localized at different positions.
Twenty-three of the VH3 sequences were highly mutated
(10–27 mutations). Except for one case, most of the muta-
tions were localized in the CDR with R:S ratio >3. Three
of seven nonfunctionally rearranged genes also revealed a
pattern of antigen-induced mutation.
VH4 genes
Seven different VH4 rearrangements could be character-
ized; six were potentially functional. CDR3 lengths ranged
from 12 to 45 bp (mean, 28 bp).
The gl genes HUMIGHCAK, HUMIGHCAG and DP63
were represented twice each, and DP71 once. No homol-
ogy to DP64/VH4-34/VH4.21 was seen. Five of the
sequences had few mutations (one to eight) with a R:S ratio
higher in the FR than in the CDR. Two VH4 rearrangements
had a R:S ratio >3 in the CDR (5c-VH44a and 3b-VH45a).
VH5 genes
Eight distinct VH5 rearrangements could be determined;
seven were potentially functional. CDR3 lengths ranged
from 12 to 66 bp (mean, 39.8 bp).
The 3a-VH54s gene was unmutated. There were 7–35
mutations in all other sequences. For five sequences (four
were potentially functional), the mutational pattern revealed
antigen induction.
Discussion
VH PCR
Analysis of rearranged VH genes from B lymphocyte DNA
by PCR and sequencing enabled characterization of the
Available online http://arthritis-research.com/content/3/3/189
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Table 2
Continued
VH Gene Functionality Germline  Homology (%) R:S ratio CDR R:S ratio FR JH CDR3 (base pairs)
4 3a-VH43b pf HUMIGHCAK 97 1/2 4/1 3 27
5c-VH44a pf HUMIGHCAK 95 8/1 3/1 6 24
3b-VH45a pf DP63 93 4/0 7/4 4 23
5c-VH44c pf DP63 99 0/1 0/0 4 27
5c-VH41a nf DP71 99 0/0 3/0 1 12
5c-VH42c pf HUMIGHCAG 98 1/0 3/0 2 30
5c-VH46b pf HUMIGHCAG > 99 1/0 0/0 6 45
5 2c-VH53b pf DP73 97 3/0 4/0 3 45
2c-VH53c pf DP73 95 2/1 8/0 3 48
2c-VH54c pf DP73 85 12/1 16/6 4 33
2c-VH54b pf DP73 95 4/1 4/3 4 or 6 39
3a-Vh53s pf DP73 96 5/0 3/4 3 66
3a-VH54s pf DP73 100 0/0 0/0 4 36
3a-VH56s nf DP73 90 13/1 7/0 5 or 6 31
3b-VH53s pf DP73 95 4/1 5/2 3 or 5 12
pf, Potentially functional; nf, nonfunctional. Referred germline genes: ‘DP’ [34]; ‘HUMIGHCAG’ and ‘HUMIGHCAK’ [35]; ‘HUMIGVH2E’ [36].
EMBL accession numbers: AJ298233-44, AJ303356-58, AJ306240-68, AJ407969-98. * Identical to F5-3a4, F5-3b4, 5c-4m6.
Figure 3
Mutated nucleotide triplets and amino acid sequence of expanded B
cell clones (a) VH1 and (b) VH3 in comparison with their respective gl
gene (short tables). The amino acid position and the CDR positions
are marked. Dashes indicate identity to the corresponding character on
top. Amino acid replacements are indicated in the last line. (For whole
sequences, see supplementary Figure 1.)clonal expansion and mutational patterns without bias due
to cell isolation procedures. By semi-nested PCR, other-
wise used for single-cell analysis [19], one sole
VH–DH–JH rearrangement might be identified. Besides
the extreme sensitivity, there is a high risk of artificial
amplifications because of contamination. A negative
control without DNA was run with each PCR as a precau-
tion: no contamination was detected. We cannot exclude
the fact that highly mutated genes are amplified less effi-
ciently [20]. However, since the respective data concern-
ing RA and ReA have been established by similar PCR
approaches [11–16], a comparison is possible.
The VH gene usage
Within 70 VH–DH–JH rearrangements characterized in
this study, all known human VH families except VH6 were
represented. The descending order of representation was:
VH3 (54%), VH1 (20%), VH5 (11%), VH4 (10%), VH2
(4%). Compared with the germline representation [5], an
over-representation of VH5 and an under-representation
of VH4 genes were remarkable. The representation of
VH1, VH2 and VH3 genes corresponded to their respec-
tive germline representation. Our previous studies of the
VH gene repertoire in RA SM [13] and studies using a
hybridoma approach [8] revealed an over-representation
of VH4 and a biased set of represented VH4 genes. A
positive selection of VH4 genes, particularly within the
plasma cell subset, was recently demonstrated in RA and
ReA [16]. The DP64/VH4-34/VH4.21 gene encoding
anti-I and anti-i specificity of cold agglutinins [21,22], as
well as anti-DNA antibodies in lupus erythmatosus [23],
was not detected within the VH4 genes from AS SM.
Another autoimmunity-prone gene, the DP47/V3-23 gene,
was also predominant in AS. All of eight V3-23-derived
genes were potentially functional rearrangements with
>3% mutations to the gl sequence, and four reveal a R:S
ratio >3 within the CDR that indicates a selection by
antigen. V3-23 was also predominant in RA SM [24]. A
comparison of the peripheral repertoire revealed that
V3-23 was more often somatically mutated in RA than in
healthy controls [9,25,26].
Except for VH4, VH5 and VH6, the representation of VH
genes was similar to results from the peripheral VH reper-
toire from healthy donors [27,9] as well as from a RA
patient [28].
Clonal expansion
Only two cases of clonal expansion characterized by iden-
tically rearranged segments were detected on different
slides. An accumulation of further point mutations in the
course of intraclonal diversification was seen in two off-
spring of a VH3 clone (both share four mutations and
differ in six point mutations). Studies on plasma cells in
ReA and RA SMs [16] reveal clonal expansion. In RA
SMs, clonal B lymphocyte expansion in different areas of
the tissue samples [11,15] and recirculation within differ-
ent joints and blood were reported [14].
The CDR3
The CDR3 lengths of genes from the AS samples were
short, with a median of 27.2 nucleotides. A high variability,
particularly in the productively rearranged subset and in the
VH5 family, was noted. A similarly high variability was shown
for polyreactive antibodies and rheumatic factors in RA [29].
Our data from RA SM revealed almost homogeneous
CDR3 lengths of intermediate size [13]. CDR3 were much
longer in the healthy peripheral repertoire, particularly within
nonfunctional rearrangements (mean, 54 nucleotides) [9].
Mutational pattern
Only nine rearrangements were not mutated. R:S ratios >3
within the CDR were observed in 30 genes (two were non-
functional). Members of the VH1, VH3, VH4 and VH5 fami-
lies carried more somatic mutations than the VH2 genes.
Mutational pattern and frequency determine about one half
of the characterized genes as memory B cells that proba-
bly stay in contact with persistent antigens in the micro-
environment of the synovial foci [30]. A similar accumulation
of memory cells in RA SM has been reported [12,31].
Besides the highly mutated genes already described, one
half of the characterized genes showed no evidence of
antigen-induced mutations with low R:S ratios within the
CDR. There was a bias to silent mutations in four highly
mutated genes (2c-3m4b, 2c-21m3, 3a-19m8 and
2c-17m9). This pattern of mutations has been described for
cold agglutinins [32], as well as for rheumatic factors, as a
mechanism of selection against amino acid replacement to
prevent the generation of high-affinity autoantibodies [33].
Nonfunctional rearrangements
Except for VH2 (none) and VH3 (18%), nonfunctional
rearrangements had an equal proportion of 13–14% in
each family within the genes characterized in the present
paper. Except for a bias to VH4, a similar overall propor-
tion of nonfunctional rearrangements was seen in the
peripheral blood of healthy donors using single-cell PCR
of genomic DNA [9]. In contrast, no bias to elevated
CDR3 lengths was seen.
Conclusion
An active immune reaction with GC formation occurs in
the inflamed SM in AS. B cell affinity maturation with gen-
eration of somatically mutated antibody-coding genes
characteristic for memory cells occurs in these GC forma-
tions, indicating an antigen-driven response. Comparable
with RA and ReA, there is a biased repertoire of selected
VH genes, whereas the panel of represented genes is dif-
ferent and clonal expansion was observed less frequently.
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Introduction
By sequence homology of at least 80%, the VH gene seg-
ments are classified into seven families. The VH1 family
has 14 members (9 genes with open reading frames),
VH2 has 4 (3 genes with open reading frames), VH3 has
65 (22 genes with open reading frames), VH4 has 32 (7
genes with open reading frames), VH5 has 2, VH6 has 1,
and VH7 has 5 members (1 gene with an open reading
frame), respectively [5].
Materials and methods
DNA preparation
After the addition of 40 ml H2O, 0.1 volume of 10 × PCR
buffer (mentioned later), 1% Triton X-100 and 0.5 ml Pro-
teinase K (100 mg/ml; Merck, Darmstadt, Germany) was
added and mixed. The volume was adapted to 80 ml by
addition of H2O. The sample was incubated over 45 min
at 55°C. After inactivation of proteinase (95°C), 25 ml of
the solution was subjected to the first PCR.
Seminested VH PCR
First PCR. An oligonucleotide mix of VH1, VH2, VH3,
VH4, VH5, VH6 and an oligonucleotide mix of JH-Intron
1,2-4,5 and JH-Intron 3,6 as primers (final concentration,
0.125 mM each), 200 mM dNTP, 2 mM MgCl2, 1 U Gold-
star Taq-polymerase (Eurogentec, Seraing, Belgium), and
the manufacturer’s reaction buffer. First cycle: 5 min
denaturation at 95°C, 3 min annealing at 58°C and
90 second extension at 72°C; cycles 2–35, 80 second
denaturation, 30 second annealing, and 90 second exten-
sion, with a final extension of 5 min.
Second PCR. One microliter of the product of the first
PCR with individual oligonucleotide primers VH1–VH6
and JH1–JH6, under the same conditions as the first PCR
except for annealing for VH1, VH2, VH5, VH6 at 58°C,
and for VH3 and VH4 at 63°C.
DNA purification and plasmid ligation were performed with
commercial kits following the manufacturer’s instructions:
DNA purification from the agarose-gel with the QUIAquick
kit (Quiagen, Hilden, Germany), and bacterial cloning with
the TA-cloning kit (Invitrogen, Leek, The Netherlands).
For DNA sequence homology search and sequence com-
parison, DNASIS software (Hitachi Europe, Olivet,
France), and EMBL Nucleotide Sequence Submissions
(European Bioinformatics Institute, Wellcome Trust
Genome Campus, Cambridge, UK) were used. The
GenBank (National Institutes of Health, Bethesda, MD,
USA) was also used.
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Supplementary Figure 1
Complete nucleotide and amino acid sequences of expanded B cell clones (a) VH1 and (b) VH3 in comparison with their respective gl gene. The
amino acid position and the CDR positions are marked. Dashes indicate identity to the corresponding character on top. Amino acid replacements
are indicated in the last line.